@mave14 The current widely used practice guidance for Polymyalgia Rheumatica (PMR) comes from the joint recommendations of the American College of Rheumatology and the European League Against Rheumatism (2015 EULAR/ACR recommendations).

Initial treatment

* Prednisone is the preferred first-line treatment.
* Recommended starting dose:
* Usually 12.5–25 mg/day prednisone
* Many patients respond well to about 15 mg/day.

Tapering recommendations

The guidelines emphasize slow individualized tapering:

1. Reduce prednisone to 10 mg/day within 4–8 weeks if symptoms are controlled.
2. After reaching 10 mg/day:
* taper by about 1 mg every 4 weeks
* avoid rapid reductions.
3. Total treatment duration:
* typically at least 12 months
* many patients require 2–3 years or longer.